Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Zippelius

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Cancer Immunology, Immunotherapy : CII|February 17, 2019
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancerMartin Sebastian, Andreas Schröder, Birgit Scheel, et al.
Science Translational Medicine|November 2, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockadeMichal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerAlexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
Nature Communications|February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapyMarcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
The Journal of Experimental Medicine|July 16, 2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophagesXiaoyun Li, Sofie Hedlund Møller, Jaeoh Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Nature Communications|September 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapyDominic Schmid, Bettina Sobottka, Massimiliano Manzo, et al.
JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8<sup>+</sup> T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|February 17, 2019
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancerMartin Sebastian, Andreas Schröder, Birgit Scheel, et al.
Science Translational Medicine|November 2, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockadeMichal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerAlexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
Nature Communications|February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapyMarcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
The Journal of Experimental Medicine|July 16, 2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophagesXiaoyun Li, Sofie Hedlund Møller, Jaeoh Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Nature Communications|September 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapyDominic Schmid, Bettina Sobottka, Massimiliano Manzo, et al.
JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8<sup>+</sup> T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Pageof 17